FCGR2B and Sepsis: Interestingly, rLcn-2 administration reduced sepsis mortality rate only in FcGRIIb-/- mice with the LPS-CLP procedures, but not in WT (Figure 9A), despite the attenuation of LPS tolerance on macrophages from both strains (Figure 8).